5660 Federal Register / Vol. 74, No. 19 / Friday, January 30, 2009 / Notices 

Health Nurses (AAOHN), and the 

American Society of Safety Engineers 

(ASSE). There is no cost to respondents. 

The estimated annualized burden hours 

are 205. 

ESTIMATED ANNUALIZED BURDEN HOURS: 

Form name Type of respondent Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

NIOSH Customer Satisfaction Survey .................. Respondents familiar with NIOSH ....................... 570 1 20/60 

Respondents not familiar with NIOSH ................. 150 1 6/60 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–2005 Filed 1–29–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-09–0234] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call the CDC Reports 

Clearance Officer at 404–639–5960 or 

send comments to CDC/ATSDR 

Assistant Reports Clearance Officer, 

1600 Clifton Road, MS–D74, Atlanta, 

GA 30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

National Ambulatory Medical Care 

Survey (NAMCS) (OMB No. 0920– 

0234)—Revision—National Center for 

Health Statistics (NCHS), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Section 306 of the Public Health 

Service (PHS) Act (42 U.S.C. 242k), as 

amended, authorizes that the Secretary 

of Health and Human Services (DHHS), 

acting through NCHS, shall collect 

statistics on ‘‘utilization of health care’’ 

in the United States. NAMCS was 

conducted annually from 1973 to 1981, 

again in 1985, and resumed as an 

annual survey in 1989. The purpose of 

NAMCS is to meet the needs and 

demands for statistical information 

about the provision of ambulatory 

medical care services in the United 

States. NCHS is seeking OMB approval 

to extend this survey for three years. 

Ambulatory services are rendered in a 

wide variety of settings, including 

physician offices and hospital 

outpatient and emergency departments. 

The NAMCS target universe consists of 

all office visits made by ambulatory 

patients to non-Federal office-based 

physicians (excluding those in the 

specialties of anesthesiology, radiology, 

and pathology) who are engaged in 

direct patient care. 

In 2006, physicians and mid-level 

providers (i.e., nurse practitioners, 

physician assistants, and nurse 

midwives) practicing in community 

health centers (CHCs) were added to the 

NAMCS sample, and these data will 

continue to be collected. To 

complement NAMCS data, NCHS 

initiated the National Hospital 

Ambulatory Medical Care Survey 

(NHAMCS, OMB No. 0920–0278) in 

1992 to provide data concerning patient 

visits to hospital outpatient and 

emergency departments. NAMCS and 

NHAMCS are the principal sources of 

data on ambulatory care provided in the 

United States. 

NAMCS provides a range of baseline 

data on the characteristics of the users 

and providers of ambulatory medical 

care. Data collected include the patients’ 

demographic characteristics, reason(s) 

for visit, provider diagnoses, diagnostic 

services, medications, and visit 

disposition. In addition, information on 

cervical cancer screening practices in 

physician offices will continue to be 

collected through the Cervical Cancer 

Screening Supplement (CCSS), which 

was added in 2006. It will allow CDC’s 

National Center for Chronic Disease 

Prevention and Health Promotion 

(NCCDPHP) to evaluate cervical cancer 

screening methods and the use of 

Human Papillomavirus DNA tests. 

A supplemental mail survey on the 

adoption and use of electronic medical 

records (EMRs) in physician offices was 

added to NAMCS in 2008, and will 

continue. These data were requested by 

the Office of the National Coordinator 

for Health Information Technology 

(ONC), Department of Health and 

Human Services, to measure progress 

toward goals for EMR adoption. The 

mail survey will collect information on 

characteristics of physician practices 

and the capabilities of EMRs used in 

those practices. 

In 2009, NAMCS will include an 

additional sample of 70 physicians to 

pretest additional questionnaire items 

on laboratory values. These new items 

were requested by the Division of Heart 

Disease and Stroke Prevention within 

NCCDPHP to better understand the 

extent to which ambulatory health care 

providers identify and control abnormal 

values before and after cardiovascular 

disease. 

Users of NAMCS data include, but are 

not limited to, Congressional offices, 

Federal agencies, state and local 

governments, schools of public health, 

colleges and universities, private 

industry, nonprofit foundations, 

professional associations, clinicians, 

researchers, administrators, and health 

planners. 

There is no cost to respondents other 

than their time to participate. 

mstockstill on PROD1PC66 with NOTICES

Federal Register / Vol. 74, No. 19 / Friday, January 30, 2009 / Notices 5661 

ESTIMATED ANNUALIZED BURDEN TABLE

Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hrs) 

Total burden 

hours 

Induction Interview—Physicians/CHC Providers ............................................. 3,480 1 28/60 1,624 

Patient Record Form ....................................................................................... 1,388 30 6/60 4,164 

CCSS ............................................................................................................... 464 1 15/60 116 

EMR Mail Survey ............................................................................................. 1,143 1 16/60 305 

CHC Induction Interview—Facility ................................................................... 104 1 18/60 31 

Total .......................................................................................................... ........................ ........................ ........................ 6,240 

Dated: January 23, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Office of 

the Chief Science Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E9–2006 Filed 1–29–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Immunology 

Integrated Review Group; Vaccines Against 

Microbial Diseases Study Section. 

Date: February 5, 2009. 

Time: 8 a.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin St. Francis, 335 Powell 

Street, San Francisco, CA 94102. 

Contact Person: Jian Wang, MD, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4218, 

MSC 7812, Bethesda, MD 20892, (301) 435– 

2778, wangjia@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; Genetics 

of Health and Disease Study Section. 

Date: February 5–6, 2009. 

Time: 8:30 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Cheryl M. Corsaro, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2204, 

MSC 7890, Bethesda, MD 20892, (301) 435– 

1045, corsaroc@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Child 

Psychopathology. 

Date: February 9, 2009. 

Time: 10 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Serrano Hotel, 405 Taylor Street, 

San Francisco, CA 94102. 

Contact Person: Dana Jeffrey Plude, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3176, 

MSC 7848, Bethesda, MD 20892, (301) 435– 

2309, pluded@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Metabolic 

Endocrinology. 

Date: February 11–12, 2009. 

Time: 8 a.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Reed A. Graves, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6166, 

MSC 7892, Bethesda, MD 20892, (301) 402– 

6297, gravesr@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Gene 

Therapy Member Conflict. 

Date: February 11, 2009. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Syed M. Quadri, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6210, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1211, quadris@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Hematopoietic Stem Cell Regulation. 

Date: February 12, 2009. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Bukhtiar H. Shah, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4120, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1233, shahb@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 22, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–1845 Filed 1–29–09; 8:45 am] 

BILLING CODE 4140–01–M 

mstockstill on PROD1PC66 with NOTICES